Chasing a diagnosis
The cancer diagnosis didn’t happen immediately.
Mike walked out of that first appointment with a preliminary finding of idiopathic thrombocytopenic purpura or ITP, which he said basically meant, “You have low platelets and we don’t know why.” The hematologist put him on high dose prednisone, which made him gain weight, feel constantly agitated, and gave him “chipmunk cheeks.”
From then on, life became much more complicated as the college sophomore juggled the normal routine of classes and friends with the surreal world of hematologists, bone marrow aspirations, uncertainty, and illness. Desperate for answers, the Rubins bounced from specialist to specialist, traveling to the Mayo Clinic in Rochester, Minnesota, to Dana Farber in Boston, back to Mount Sinai in New York.
“We went to every hospital in the nation,” said Mike’s father, Milt, now an 80-year-old retired assets manager living in Manhattan. “It went on for a long time.”
What neither the family — nor the doctors — knew at the time was that Mike had a pre-leukemia condition known as myelodysplasia. Researchers were still discovering the secrets of deadly blood cancers and how to treat them, and many doctors believed myelodysplasia only happened to the elderly.
“The long period of uncertainty was very unsettling,” Mike said, looking back. “I felt like a pinball getting bounced around. But at the time, pre-leukemia was something they were just learning about.”
Researchers in Seattle were also learning that some blood cancers could be treated, and perhaps even cured, through a grueling procedure known as a bone marrow transplant, which first destroyed the patient’s flawed marrow — and with it, their immune system — then replaced it with someone else’s.
In 1987, after five years of hospital stays, steroids, blood tests and brutal bone marrow biopsies, Mike’s disease finally progressed to what is now known as acute myeloid leukemia, or AML. Without treatment, he would live only a few months. With treatment, there was still a 50 percent chance he would die. Signing on for a BMT was a terrifying choice, but the Rubins made it and never looked back. Nor did they question where they would go for the procedure.
“We had done the donor typing a couple of years before and knew Jude was the appropriate donor,” Mike said. “And we knew that the Hutch was the place to go.”
Milt, in fact, had always known where he would take his gravely ill son when the time came.
“The oncologist said, ‘He’s going to need a bone marrow transplant. And when it’s time you’ll go to Seattle to Fred Hutch,’” he said. “We were never anything but ecstatic about going there. We knew it was the best. They pioneered it.”
Seattle, city of transplants
Shortly after learning Mike qualified for a BMT, the Long Island family packed their bags and headed for Seattle and Fred Hutch, which at the time was on First Hill.